肺肾综合征常被认为是快速致死性疾病。晚近由于对抗肾小球基底膜(GBM)抗体的病理和检测技术的日趋精确,对本病已有了进一步的认识。随着诊断技术和治疗方法的改进,本病预后获得改善。对于非透析的抗GBM肾炎患者,血浆胃换和免疫抑制剂的治疗在控制肺出血和保护肾功能起着一定的作用。然而,少尿一无尿型抗GBM肾炎的残余肾功能已极少,其预后不良。最近,我们对这种患者不给予 Pulmonary-renal syndrome is often considered a fast-fatal disease. Recently, as the anti-glomerular basement membrane (GBM) antibody pathology and detection of increasingly accurate technology, the disease has been further understanding. With the improvement of diagnostic techniques and treatment methods, the prognosis of this disease is improved. For non-dialysis patients with anti-GBM nephritis, plasma gas exchange and immunosuppressive agents may play a role in controlling pulmonary hemorrhage and protecting renal function. However, the residual renal function of oliguria-anuria-type anti-GBM nephritis has been minimal and its prognosis is poor. Recently, we did not give this kind of patient